1. Home
  2. HSDT vs AVGR Comparison

HSDT vs AVGR Comparison

Compare HSDT & AVGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • AVGR
  • Stock Information
  • Founded
  • HSDT 2014
  • AVGR 2007
  • Country
  • HSDT United States
  • AVGR United States
  • Employees
  • HSDT N/A
  • AVGR N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AVGR Medical/Dental Instruments
  • Sector
  • HSDT Health Care
  • AVGR Health Care
  • Exchange
  • HSDT Nasdaq
  • AVGR Nasdaq
  • Market Cap
  • HSDT 2.5M
  • AVGR 2.0M
  • IPO Year
  • HSDT N/A
  • AVGR 2015
  • Fundamental
  • Price
  • HSDT $0.49
  • AVGR $0.49
  • Analyst Decision
  • HSDT Buy
  • AVGR Strong Buy
  • Analyst Count
  • HSDT 2
  • AVGR 1
  • Target Price
  • HSDT $24.00
  • AVGR $5.00
  • AVG Volume (30 Days)
  • HSDT 236.6K
  • AVGR 194.1K
  • Earning Date
  • HSDT 11-12-2024
  • AVGR 11-07-2024
  • Dividend Yield
  • HSDT N/A
  • AVGR N/A
  • EPS Growth
  • HSDT N/A
  • AVGR N/A
  • EPS
  • HSDT N/A
  • AVGR N/A
  • Revenue
  • HSDT $502,000.00
  • AVGR $7,262,000.00
  • Revenue This Year
  • HSDT N/A
  • AVGR N/A
  • Revenue Next Year
  • HSDT $8.97
  • AVGR $93.49
  • P/E Ratio
  • HSDT N/A
  • AVGR N/A
  • Revenue Growth
  • HSDT N/A
  • AVGR N/A
  • 52 Week Low
  • HSDT $0.37
  • AVGR $0.39
  • 52 Week High
  • HSDT $9.50
  • AVGR $5.45
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 44.03
  • AVGR 22.72
  • Support Level
  • HSDT $0.43
  • AVGR $0.42
  • Resistance Level
  • HSDT $0.76
  • AVGR $0.73
  • Average True Range (ATR)
  • HSDT 0.08
  • AVGR 0.09
  • MACD
  • HSDT -0.01
  • AVGR -0.03
  • Stochastic Oscillator
  • HSDT 17.91
  • AVGR 21.80

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About AVGR Avinger Inc.

Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.

Share on Social Networks: